SOLU-CORTEF Sterile Powder is available in the following packages:
100 mg Plain—NDC 0009-0825-01 | |
100 mg ACT-O-VIAL (Single-Dose Vial) | 250 mg ACT-O-VIAL (Single-Dose Vial) |
2 mL—NDC 0009-0011-03 | 2 mL—NDC 0009-0013-05 |
25 × 2 mL—NDC 0009-0011-04 | 25 × 2 mL—NDC 0009-0013-06 |
500 mg ACT-O-VIAL (Single-Dose Vial)—NDC 0009-0016-12 | |
1,000 mg ACT-O-VIAL (Single-Dose Vial)—NDC 0009-0005-01 |
Store unreconstituted product at controlled room temperature 20°C to 25°C (68°F to 77°F).
Store reconstituted and/or further diluted solution at controlled room temperature 20°C to 25°C (68°F to 77°F) and protect from light. Use the reconstituted and/or further diluted solution within 12 hours of preparation. Use reconstituted/diluted solution only if it is clear. If kept at controlled room temperature unused reconstituted and/or further diluted solution should be discarded after 12 hours post preparation. If kept under refrigerated conditions, unused reconstituted and/or further diluted solution should be used in no more than 24 hours and any unused portion should be discarded after that time.
For medical information about SOLU‑CORTEF, please visit www.pfizermedinfo.com or call 1‑800‑438‑1985. This product's label may have been updated. For current full prescribing information please visit www.pfizer.com
SOLU-CORTEF Sterile Powder is available in the following packages:
100 mg Plain—NDC 0009-0825-01 | |
100 mg ACT-O-VIAL (Single-Dose Vial) | 250 mg ACT-O-VIAL (Single-Dose Vial) |
2 mL—NDC 0009-0011-03 | 2 mL—NDC 0009-0013-05 |
25 × 2 mL—NDC 0009-0011-04 | 25 × 2 mL—NDC 0009-0013-06 |
500 mg ACT-O-VIAL (Single-Dose Vial)—NDC 0009-0016-12 | |
1,000 mg ACT-O-VIAL (Single-Dose Vial)—NDC 0009-0005-01 |
Store unreconstituted product at controlled room temperature 20°C to 25°C (68°F to 77°F).
Store reconstituted and/or further diluted solution at controlled room temperature 20°C to 25°C (68°F to 77°F) and protect from light. Use the reconstituted and/or further diluted solution within 12 hours of preparation. Use reconstituted/diluted solution only if it is clear. If kept at controlled room temperature unused reconstituted and/or further diluted solution should be discarded after 12 hours post preparation. If kept under refrigerated conditions, unused reconstituted and/or further diluted solution should be used in no more than 24 hours and any unused portion should be discarded after that time.
For medical information about SOLU‑CORTEF, please visit www.pfizermedinfo.com or call 1‑800‑438‑1985. This product's label may have been updated. For current full prescribing information please visit www.pfizer.com
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.